Abstract
Background: Alzheimer’s disease (AD) is one of the most devastating diseases worldwide. The current drugs for AD can only ameliorate the symptoms rather than reverse or prevent the progress of AD. On the other hand, blood-brain barrier (BBB), as a natural barrier, significantly impedes drug delivery from the blood circulation into the brain. Nanomedicine can be a safe, effective and promising approach to treat AD.
Objective: This review summarizes the recent nanomedicine research in this area, including the use of liposomes and nanoparticles (NPs), to provide new approach for targeted treatment of AD.
Method: Collecting and referring to the related literature in recent 10 years, via searching MeSH Terms “Alzheimer's disease; nanomedicine; nanoparticle; amyloid β peptide; tau protein; autophagy”.
Results: Nanomedicines show superiority over conventional anti-AD drugs as a potential weapon against AD by the five proposed mechanisms: many unfavorable pharmaceutical properties of conventional anti-AD drugs maybe greatly overcome by nanomedicine; nanomedicines trigger efficient production of high-titer anti-Aβ antibodies following controlled release of antigens by them; some apolipoprotein- based nanomedicines could preferably bind to Aβ and increase the elimination of Aβ; nanomedicine-induced autophagy could be facilitated to increase the elimination of Aβ; nanomedicineinduced inhibition of tau aggregation.
Conclusion: Therefore, nanomedicine-mediated drug therapy is promising in the treatment of AD.
Keywords: Alzheimer`s disease, nanomedicine, nanoparticle, amyloid β peptide, tau protein, BBB.
Mini-Reviews in Medicinal Chemistry
Title:Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease
Volume: 18 Issue: 12
Author(s): Tian-Jun Ma , Jie Gao, Yan Liu, Jian-Hua Zhuang, Chuan Yin, Peng Li, Lei Mao, Jin Xu , Yi-Xin Xu, Yan-Peng Li , Zhong-Xin Zhao and You Yin*
Affiliation:
- Department of Neurology, Changzheng Hospital, Second Military Medical University, Shanghai 200003,China
Keywords: Alzheimer`s disease, nanomedicine, nanoparticle, amyloid β peptide, tau protein, BBB.
Abstract: Background: Alzheimer’s disease (AD) is one of the most devastating diseases worldwide. The current drugs for AD can only ameliorate the symptoms rather than reverse or prevent the progress of AD. On the other hand, blood-brain barrier (BBB), as a natural barrier, significantly impedes drug delivery from the blood circulation into the brain. Nanomedicine can be a safe, effective and promising approach to treat AD.
Objective: This review summarizes the recent nanomedicine research in this area, including the use of liposomes and nanoparticles (NPs), to provide new approach for targeted treatment of AD.
Method: Collecting and referring to the related literature in recent 10 years, via searching MeSH Terms “Alzheimer's disease; nanomedicine; nanoparticle; amyloid β peptide; tau protein; autophagy”.
Results: Nanomedicines show superiority over conventional anti-AD drugs as a potential weapon against AD by the five proposed mechanisms: many unfavorable pharmaceutical properties of conventional anti-AD drugs maybe greatly overcome by nanomedicine; nanomedicines trigger efficient production of high-titer anti-Aβ antibodies following controlled release of antigens by them; some apolipoprotein- based nanomedicines could preferably bind to Aβ and increase the elimination of Aβ; nanomedicine-induced autophagy could be facilitated to increase the elimination of Aβ; nanomedicineinduced inhibition of tau aggregation.
Conclusion: Therefore, nanomedicine-mediated drug therapy is promising in the treatment of AD.
Export Options
About this article
Cite this article as:
Ma Tian-Jun , Gao Jie , Liu Yan, Zhuang Jian-Hua, Yin Chuan , Li Peng , Mao Lei , Xu Jin , Xu Yi-Xin, Li Yan-Peng , Zhao Zhong-Xin and Yin You *, Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease, Mini-Reviews in Medicinal Chemistry 2018; 18 (12) . https://dx.doi.org/10.2174/1389557518666171215150024
DOI https://dx.doi.org/10.2174/1389557518666171215150024 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Incorporating Link Information in Feature Selection for Identifying Tumor Biomarkers by Using miRNA-mRNA Paired Expression Data
Current Proteomics Possibilities of Poly(D,L-lactide-co-glycolide) in the Formulation of Nanomedicines Against Cancer
Current Drug Targets Interpreting the Mechanisms by which Integrins Promote the Differentiation of Mesenchymal Stem Cells and Integrin Application Prospects
Current Stem Cell Research & Therapy Protective Effect of <i>Nerium oleander</i> Distillate and <i>Tarantula cubensis</i> Alcoholic Extract on Cancer Biomarkers in Colon and Liver Tissues of Rats with Experimental Colon Cancer
Anti-Cancer Agents in Medicinal Chemistry Mitochondria-Targeting Anticancer Metal Complexes
Current Medicinal Chemistry Editorial [Hot Topic: Development of Drugs Interfering with Apoptosis (Executive Guest Editor: Sebastiano Cavallaro)]
Current Pharmaceutical Design Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials Overview of the Formulations and Analogs in the Taxanes' Story
Current Medicinal Chemistry Efficacy and Safety of Bevacizumab in Glioblastomas
Current Medicinal Chemistry Hemisynthesis of Selected Embelin Analogs and Investigation of their Proapoptotic Activity Against Cancer Cells
Medicinal Chemistry Peptide modules for overcoming barriers of nucleic acids transport to cells
Current Topics in Medicinal Chemistry New Functions of the Inositol Polyphosphate 5-Phosphatases in Cancer
Current Pharmaceutical Design Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB
Anti-Cancer Agents in Medicinal Chemistry Integrin Function and Signaling as Pharmacological Targets in Cardiovascular Diseases and in Cancer
Current Pharmaceutical Design Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Recent Patents on Anti-Cancer Drug Discovery Convection-Enhanced Delivery: Neurosurgical Issues
Current Drug Targets Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma
Current Cancer Therapy Reviews Nutlins and Ionizing Radiation in Cancer Therapy
Current Pharmaceutical Design